arav in d reports

4
S02 - DR ANMOL_S ULTRASOUND CLINIC C-308, 3RD FLR, NIRWANA COUNTRY, SOUTH CITY GURGAON Name A/c Status Lab No. Ref By : Gender: Age: Report Status Reported Received Collected P 19/4/2014 4:55:39PM : : : : : : : Final 38 Years 19/4/2014 12:12:00PM 19/4/2014 12:22:00PM 107521813 Male SELF Mr. ARVIND Test Name Results Units Ref. Range ALBUMIN, SERUM (BCG) 4.71 g/dL 3.50 - 5.20 UREA, SERUM (Urease UV) 28.00 mg/dL 17.00 - 43.00 CREATININE, SERUM (Compensated Jaffe's reaction, IDMS traceable) 0.94 mg/dL 0.67 - 1.17 AST (SGOT), SERUM (IFCC) 27.00 U/L <50.00 ALT (SGPT), SERUM (IFCC) 37.00 U/L <50.00 BLOOD GROUP, ABO & RH TYPING @ (Erythrocyte Magnetized Technology) ABO Group B Rh Factor Positive Note: 1. Both forward and reverse grouping performed 2. Test conducted on EDTA whole blood PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 4) . Page 1 of 4

Upload: suganthiaravind

Post on 07-Feb-2016

15 views

Category:

Documents


2 download

DESCRIPTION

arav

TRANSCRIPT

Page 1: Arav in d Reports

S02 - DR ANMOL_S

ULTRASOUND CLINIC

C-308, 3RD FLR, NIRWANA

COUNTRY, SOUTH CITY

GURGAON

Name

A/c Status

Lab No.

Ref By :

Gender:Age:

Report Status

Reported

Received

Collected

P

19/4/2014 4:55:39PM

:

:

:

:

:

:

: Final

38 Years

19/4/2014 12:12:00PM

19/4/2014 12:22:00PM107521813 Male

SELF

Mr. ARVIND

Test Name Results Units Ref. Range

ALBUMIN, SERUM

(BCG)

4.71 g/dL 3.50 - 5.20

UREA, SERUM

(Urease UV)

28.00 mg/dL 17.00 - 43.00

CREATININE, SERUM

(Compensated Jaffe's reaction, IDMS traceable)

0.94 mg/dL 0.67 - 1.17

AST (SGOT), SERUM

(IFCC)

27.00 U/L <50.00

ALT (SGPT), SERUM

(IFCC)

37.00 U/L <50.00

BLOOD GROUP, ABO & RH TYPING @

(Erythrocyte Magnetized Technology)

ABO Group B

Rh Factor Positive

Note: 1. Both forward and reverse grouping performed

2. Test conducted on EDTA whole blood

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 4)

.

Page 1 of 4

Page 2: Arav in d Reports

S02 - DR ANMOL_S

ULTRASOUND CLINIC

C-308, 3RD FLR, NIRWANA

COUNTRY, SOUTH CITY

GURGAON

Name

A/c Status

Lab No.

Ref By :

Gender:Age:

Report Status

Reported

Received

Collected

P

19/4/2014 4:55:44PM

:

:

:

:

:

:

: Final

38 Years

19/4/2014 12:12:00PM

19/4/2014 12:22:00PM107521813 Male

SELF

Mr. ARVIND

Test Name Results Units Ref. Range

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD

(HPLC)

5.70 %

Interpretation ------------------------------------------------------------------------------- | As per American Diabetes Association (ADA) ||-------------------------------------------------------------------------------| | Reference Group | HbA1c in % ||-------------------------------|-----------------------------------------------| | Non diabetic adults >=18 years| 4.0 - 6.0 | |-------------------------------|-----------------------------------------------| | At risk | >=6.0 to <= 6.5 | |-------------------------------|-----------------------------------------------| | Diagnosing Diabetes | > 6.5 ||-------------------------------|-----------------------------------------------|| Therapeutic goals for glycemic| Adults || control | . Goal of therapy: < 7.0 || | . Action suggested: > 8.0 || | Pediatric patients || | . Toddlers & Preschoolers: > 7.5 to < 8.5 || | . 6 - 12 years : < 8.0 || | . 13 - 19 years : < 7.5 | -------------------------------------------------------------------------------

Note: 1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a

diabetic patient who is recently under good control may still have a high concentration of

HbA1c. Converse is true for a diabetic previously under good control but now poorly

controlled .

2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long

life expectancy and no significant cardiovascular disease. In patients with significant

complications of diabetes, limited life expectancy or extensive co-morbid conditions,

targeting a goal of < 7.0 % may not be appropriate.

Comments

HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better

indicator of long term glycemic control as compared to blood and urinary glucose determinations.

ADA criteria for correlation between HbA1c & Mean plasma glucose levels

--------------------------------------- | HbA1c(%) | Mean Plasma Glucose (mg/dL)| |----------|----------------------------| | 6 | 126 | |----------|----------------------------| | 7 | 154 | |----------|----------------------------| | 8 | 183 | |----------|----------------------------|

PatientReportSCSuperPanel.HBELECTRO_SC (Version: 4)

.

Page 2 of 4

Page 3: Arav in d Reports

S02 - DR ANMOL_S

ULTRASOUND CLINIC

C-308, 3RD FLR, NIRWANA

COUNTRY, SOUTH CITY

GURGAON

Name

A/c Status

Lab No.

Ref By :

Gender:Age:

Report Status

Reported

Received

Collected

P

19/4/2014 4:55:44PM

:

:

:

:

:

:

: Final

38 Years

19/4/2014 12:12:00PM

19/4/2014 12:22:00PM107521813 Male

SELF

Mr. ARVIND

Test Name Results Units Ref. Range | 9 | 212 | |----------|----------------------------| | 10 | 240 | |----------|----------------------------| | 11 | 269 | |----------|----------------------------| | 12 | 298 | ---------------------------------------

PatientReportSCSuperPanel.HBELECTRO_SC (Version: 4)

.

Page 3 of 4

Page 4: Arav in d Reports

S02 - DR ANMOL_S

ULTRASOUND CLINIC

C-308, 3RD FLR, NIRWANA

COUNTRY, SOUTH CITY

GURGAON

Name

A/c Status

Lab No.

Ref By :

Gender: Age:

Report Status

Reported

Received

Collected

P

19/4/2014 4:56:04PM

:

:

:

:

:

:

: Final

38 Years

19/4/2014 12:12:00PM

19/4/2014 12:22:00PM107521813 Male

SELF

Mr. ARVIND

Test Name Results Units Ref. Range

GLUCOSE, FASTING (F) AND POST MEAL, PLASMA

(Hexokinase)

88.00Glucose Fasting 70.00 - 100.00 mg/dL

97.00Glucose (PP) 70.00 - 140.00 mg/dL

Dr. Divya.Singh

MD PATH

Chief of Lab

Dr. Sushrut Pownikar

DNB (Pathology)

HOD Hemat & Imm

-------------------------------End of report --------------------------------

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 3)

.

Page 4 of 4